2. El-Kott A.F., Ismaeil M.F., El-Moneim M.M. et al. Histogenesis of human renal cell carcinoma by using electron microscopy and immunohistochemical techniques. Int Urol Nephrol. 2005; 37 (3): 439–45. Doi: 10.1007/s11255-004-6103-4.

3. Ma J., Zhou X.J., Huang W.B., Zhou H.B. et al. Clinicopathologic study of renal cell carcinoma with rhabdoid features. Zhonghua Bing Li Xue Za Zhi. 2007; 36 (3): 166–70. Doi: 10.3760.

4. Tickoo S.K., Lee M.W., Eble J.N. Ultrastructural observations on mitochondria and microvesicles in renal oncocytoma, chromophobe renal cell carcinoma, and eosinophilic variant of conventional (clear cell) renal cell carcinoma. Am J Surg Pathol. 2000; 24 (9): 1247–56. Doi: 10.1097/00000478-200009000-00008.

5. Cheng L., Bostwick D.G. Urologic Surgical pathology. 2014; 86–88. ISBN: 978-1-4557-4327-8.

6. Shi S.S., Shen Q., Xia Q.Y. et al. Clear cell papillary renal cell carcinoma: a clinicopathological study emphasizing ultrastructural features and cytogenetic heterogeneity. Int J Clin Exp Pathol. 2013 Nov 15;6(12):2936–42.

7. Williamson S.R., Hornick J.L., Eble J.N. et al. Renal cell carcinoma with angioleiomyoma-like stroma and clear cell papillary renal cell carcinoma: exploring SDHB protein immunohistochemistry and the relationship to tuberous sclerosis complex. Hum Pathol. 2018;75:10–15. Doi: 10.1016/j.humpath.2017.11.013.

8. Heidarian A., Banihashemi A., Wieczorek R. et al. Synchronous Chromophobe Renal Cell Carcinoma and Papillary Renal Cell Carcinoma: Supportive Evidence for the Cancer Stem Cell Hypothesis. American Journal of Clinical Pathology. 2018;150(1):S52.

9. Hes O., Brunelli M., Michal M. et al. Oncocytic papillary renal cell carcinoma: a clinicopathologic, immunohistochemical, ultrastructural, and interphase cytogenetic study of 12 cases. Ann Diagn Pathol. 2006;10(3):133–139. Doi: 10.1016/j.anndiagpath.2005.12.002.

10. Krishnan B., Truong L.D. Renal epithelial neoplasms: the diagnostic implications of electron microscopic study in 55 cases. Hum Pathol. 2002;33(1):68–79. Doi: 10.1053/hupa.2002.30210.

11. Danbara N., Shikata N., Kawamura H. et al. Eosinophilic cytoplasmic inclusions in papillary renal cell carcinoma. Med Mol Morphol 38,262(2005). Doi: 10.1007/s00795-005-0286-3.

12. Cohen R.J., Weinstein S., Robertson T. et al. Variant Chromophobe Renal Cell Carcinoma. Arch Pathol Lab Med. 2000;124:904–906. Doi: 10.5858/2000-124-0904-VCRCC.

13. Johnson N.B., Johnson M.M., Selig M.K. et al. Use of Electron Microscopy in Core Biopsy Diagnosis of Oncocytic Renal Tumors. J Ultrastructural Pathology. 2010;34(4):189–194. Doi: 10.3109/01913121003725713.

14. Liu J., Fanning C.V. Can renal oncocytomas be distinguished from renal cell carcinoma on fine-needle aspiration specimens? A study of conventional smears in conjunction with ancillary studies. Cancer. 2001;93(6):390–397. Doi: 10.1002/cncr.10141.

15. Yusenko M.V. Molecular pathology of chromophobe renal cell carcinoma: A review. International Journal of Urology. 2010;17:592–601. Doi: 10.1111/j.1442-2042.2010.02558.x.

16. Kuroda N., Toi M., Hiroi M. et al. Review of chromophobe renal cell carcinoma with focus on clinical and pathobiological aspects. J Histology and Histopathology. 2003;18:165–71. Doi: 10.14670/HH-18.165.

17. Pusiol T., Franceschetti I., Scialpi M. et al. Electron microscopy: the gold standard in the differential diagnosis of chromophobe renal cell carcinoma and oncocytoma. Anal Quant Cytol Histol. 2010;32(1):58–60.

18. Skinnider B.F., Jones E.C. Renal oncocytoma and chromophobe renal cell carcinoma. A comparison of colloidal iron staining and electron microscopy. Am J Clin Pathol. 1999;111(6):796–803. Doi: 10.1093/ajcp/111.6.796.

19. Li M., Vuolo M.A., Weidenheim K.M. et al. Collecting-duct carcinoma of the kidney with prominent signet ring cell features. Mod Pathol. 2001 Jun;14(6):623–628. Doi: 10.1038/modpathol.3880361.

20. Mardi K., Biswas B. Collecting-duct carcinoma of the kidney with prominent signet ring cell features. J Clinical Cancer investigation. 2012;1(3):170–72.

21. Elliott , Bruner E. Renal Medullary Carcinoma. Archives of Pathology & Laboratory Medicine. 2019;143(12):1556–1561. Doi: 10.5858/arpa.2017-0492-RS.

22. Wartchow E.P., Trost B.A., Tucker J.A. et al. Renal medullary carcinoma: ultrastructural studies may benefit diagnosis. Ultrastruct Pathol. 2008;32(6):252–256. Doi: 10.1080/01913120802591875.

23. Yang X., Sugimura J., Tretiakova M. et al. Gene Expression Profiling of Renal Medullary Carcinoma. J Cancer. 2004;100:976–985. Doi: 10.1002/cncr.20049.

24. Krishnan B., Truong L.D. Renal epithelial neoplasms: the diagnostic implications of electron microscopic study in 55 cases. Hum Pathol. 2002;33(1):68–79. Doi: 10.1053/hupa.2002.30210.

25. Macke R.A., Hussain M.B., Imray T..J et al. Osteogenic and sarcomatoid differentiation of a renal cell carcinoma. Cancer. 1985;56(10):2452–57. Doi: 10.1002/1097-0142(19851115)56:10<2452::aid-cncr2820561021>3.0.co;2-c.

26. Talento R., Hewan-Love K., Yin M. Evaluation of Morphologically Unclassified Renal Cell Carcinoma with Electron Microscopy and Novel Renal Markers: Implications for Tumor Reclassification. Ultrastruct Pathol. 2013;37(1):70–76. Doi: 10.3109/01913123.2012.739595.

27. Banerjee I., Yadav S., Tomar V. et al. Tubulocystic Renal Cell Carcinoma: A Great Imitator. Rev Urol. 2016;18(2):118–21. Doi: 10.3909/riu0692.

28. Bhullar J.S., Bindroo S., Varshney N. et al. Tubulocystic Renal Cell Carcinoma: A Rare Renal Tumor. J Kidney Cancer VHL. 2014;1(5):56–62. Doi: 10.15586/jkcvhl.2014.13.

29. Alexiev B.A., Burke A.P., Drachenberg C.B. et al. Mucinous tubular and spindle cell carcinoma of the kidney with prominent papillary component, a non-classic morphologic variant. A histologic, immunohistochemical, electron microscopic and fluorescence in situ hybridization study. Pathol Res Pract. 2014 Jul; 210(7):454–458. Doi: 10.1016/j.prp.2014.03.002.

30. Jung S.J., Yoon H.K., Chung J. et al. Mucinous tubular and spindle cell carcinoma of the kidney with neuroendocrine differentiation. Am J Clin Pathol 2006;125:99–104.

31. Kuroda N., Nakamura S., Miyazaki E. et al. Low-grade tubular-mucinous renal neoplasm with neuroendocrine differentiation: a histological, immunohistochemical and ultrastructural study. Pathol Int. 2004;54(3):201–207. Doi: 10.1111/j.1440-1827.2004.01608.x.

32. Trpkov K., Hes O., Bonert M. et al. Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women. Am J Surg Pathol. 2016;40(1):60–71. Doi: 10.1097/PAS.0000000000000508.

33. Smirnova E.A., Bezhanova S.D., Kozlov N.A. et al. Renal cell carcinoma associated with Xp11 translocations involving the TFE3 gene. Archive of Pathology. 2018;1:58–62. Russian (Смирнова Е.А., Бежанова С.Д., Козлов Н.А. и др. Почечно-клеточный рак, ассоциированный с Хр11-транслокацией гена TFE3. Архив патологии. 2018;1:58–62). Doi: 10.17116/patol201880158-62.

34. Meyer P.N., Clark J., Flanigan R.C. et al. Xp11.2 Translocation Renal Cell Carcinoma With Very Aggressive Course in Five Adults. Am J Clin Pathol. 2007; 128:70–79. Doi: 10.1309/LR5G1VMXPY3G0CUK.

35. Xia Q.Y., Wang X.T., Zhan X.M. et al. Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC: Interest and Diagnostic Pitfall in Detecting a Paracentric Inversion of TFE3. Am J Surg Pathol. 2017;41(5):663–676. Doi: 10.1097/PAS.0000000000000837.

36. Bernstein J., Evan A., Gardner K. Epithelial Hyperplasia in Human Polycystic Kidney Diseases. American Journal of Pathology. 1987;129(1):92–101.

37. Kuroda N, Tamura M, Taguchi T et al. Sarcomatoid acquired cystic disease-associated renal cell carcinoma. J Histology and Histopathology. 2008;23(11):1327–1331. Doi: 10.14670/HH-23.1327.

38. Mickisch O., Bommer J., Bachmann S. et al. Multicystic Transformation of Kidneys in Chronic Renal Failure. J Nephron. 1984;38:93–99. Doi: 10.1159/000183288.

39. Housley S.L., Lindsay R.S., Young B. et al. Renal carcinoma with giant mitochondria associated with germ-line mutation and somatic loss of the succinate dehydrogenase B gene. Histopathology. 2010;56(3):405–408. Doi: 10.1111/j.1365-2559.2010.03482.x.

40. Tsai .T, Lee W. Succinate Dehydrogenase–Deficient Renal Cell Carcinoma. Archives of Pathology & Laboratory Medicine. 2019;1(143):643–647. Doi: 10.5858/arpa.2018-0024-RS.

41. Tong W., Sourbier C., Kovtunovych G. et al. The Glycolytic Shift in Fumarate-Hydratase-Deficient Kidney Cancer Lowers AMPK Levels, Increases Anabolic Propensities and Lowers Cellular Iron Levels. J Cancer Cell. 2011;20(3):315–327. Doi: 10.1016/j.ccr.2011.07.018.

42. Yang Y., Valera V.A., Padilla-Nash H.M. et al. UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet. 2010;196(1):45–55. Doi: 10.1016/j.cancergencyto.2009.08.018.